What is already known about this subject:
- Cell-based products are diverse and innovative in nature, for which
requirements for non-clinical development are not yet crystallised.
- The relevance of in vivo animal studies for cell-based products
is limited by species specificity.
- Evaluation of biodistribution profile and tumourigenic risk is vital
to the non-clinical development program of cell-based products.